GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » PB Ratio

Cryofocus Medtech (Shanghai) Co (HKSE:06922) PB Ratio : 15.58 (As of Jul. 07, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-07-07), Cryofocus Medtech (Shanghai) Co's share price is HK$5.14. Cryofocus Medtech (Shanghai) Co's Book Value per Share for the quarter that ended in Dec. 2024 was HK$0.33. Hence, Cryofocus Medtech (Shanghai) Co's PB Ratio of today is 15.58.

The historical rank and industry rank for Cryofocus Medtech (Shanghai) Co's PB Ratio or its related term are showing as below:

HKSE:06922' s PB Ratio Range Over the Past 10 Years
Min: 8.65   Med: 15.11   Max: 24.74
Current: 15.58

During the past 5 years, Cryofocus Medtech (Shanghai) Co's highest PB Ratio was 24.74. The lowest was 8.65. And the median was 15.11.

HKSE:06922's PB Ratio is ranked worse than
95.55% of 786 companies
in the Medical Devices & Instruments industry
Industry Median: 2.23 vs HKSE:06922: 15.58

During the past 12 months, Cryofocus Medtech (Shanghai) Co's average Book Value Per Share Growth Rate was -55.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -27.70% per year.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Cryofocus Medtech (Shanghai) Co was 43.70% per year. The lowest was -27.70% per year. And the median was 8.00% per year.

Back to Basics: PB Ratio


Cryofocus Medtech (Shanghai) Co PB Ratio Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co PB Ratio Chart

Cryofocus Medtech (Shanghai) Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
- - 15.81 25.47 24.73

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
PB Ratio Get a 7-Day Free Trial 15.81 18.91 25.47 14.15 24.73

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's PB Ratio

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryofocus Medtech (Shanghai) Co's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's PB Ratio falls into.


;
;

Cryofocus Medtech (Shanghai) Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Cryofocus Medtech (Shanghai) Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=5.14/0.33
=15.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Cryofocus Medtech (Shanghai) Co  (HKSE:06922) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Cryofocus Medtech (Shanghai) Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryofocus Medtech (Shanghai) Co Business Description

Traded in Other Exchanges
N/A
Address
Lane 3399, Kangxin Road, Building 15, Pudong New Area, Shanghai, CHN, 200120
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products. The company uses liquid nitrogen as the main cryogenic source for cryotherapy systems by leveraging liquid nitrogen cryoablation technology and flexible catheter technology. The products offered by the company include: Bladder Cryoablation System, Pulmonary Nodule Localization Needle, and Endoscopic Clip for Anastomosis, among others. Geographically, the company's revenue is generated from the sale of medical consumables and devices in the Chinese Mainland.
Executives
Zhuhai Junheng Investment L.p. (limited Partnership) 2101 Beneficial owner
Shang Hai Shi Di Sheng Wu Ke Ji You Xian Gong Si
Lv Shiwen 2103 Interests held jointly with another person
Shenzhen Gao Ling Tiancheng Iii Investment Co., Ltd. 2201 Interest of corporation controlled by you
Ning Bo Lin Feng Sheng Wu Ke Ji You Xian Gong Si
Wu Jianhui 2101 Beneficial owner
Li Hui 2202 Interest of your spouse
Shang Hai Shi Di Shi Ye Fa Zhan You Xian Gong Si
Sun Xiaolu 2201 Interest of corporation controlled by you
Fu Guo Ji Jin Guan Li You Xian Gong Si 2102 Investment manager
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi He Huo Qi Ye You Xian He Huo
Shang Hai Bi Lin Xing Zi Chan Guan Li You Xian Gong Si
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Sheng Shan Zi Chan Guan Li Shang Hai You Xian Gong Si
Gan Shi Xiong

Cryofocus Medtech (Shanghai) Co Headlines

No Headlines